PRVA — Privia Health Group, Inc.

Summary of Privia Health (PRVA) Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue: Practice collections increased by 14.6% year-over-year to $914.8 million.
• Adjusted EBITDA: Rose 36.3% to $36.7 million, with an EBITDA margin of 28.5%, reflecting a 290 basis point improvement.
• Provider Growth: Total implemented providers reached 5,535, a 13.6% increase year-over-year.
• Attributed Lives: Grew by 26.5% to 1.6 million, with significant increases in Medicare and Medicaid segments.
• Cash Position: Ended the quarter with $219.5 million in cash and no debt.

2. Strategic Updates and Business Highlights

• Operational Execution: Strong performance attributed to effective execution across diversified markets, with high gross provider retention and patient satisfaction scores.
• Market Expansion: Privia now operates in 24 states and the District of Columbia, with plans for further organic and inorganic growth.
• Technology Initiatives: New Chief Technology Officer appointed to enhance technology stack, including AI applications aimed at improving operational efficiency and patient care.
• Provider Referral Strength: High rates of provider-to-provider referrals, with existing providers acting as effective sales agents for new signings.

3. Forward Guidance and Outlook

• 2026 Guidance: Maintained for most metrics, with an increase in the range for attributed lives due to strong Q1 performance. Expected adjusted EBITDA growth of approximately 20% at the midpoint, with 80% of EBITDA anticipated to convert to free cash flow.
• Long-Term Goals: Focus on sustainable earnings growth and continued expansion in value-based care arrangements.

4. Bad News, Challenges, or Points of Concern

• Conservative Guidance: While Q1 results were strong, management opted for a conservative approach in maintaining guidance, suggesting potential caution in future performance.
• Shared Savings Outlook: Uncertainty regarding shared savings growth, with management indicating it may not remain flat if current trends continue, but data is still being evaluated.
• Risk Appetite: Management reiterated a preference for shared risk models over full capitation, indicating a cautious approach to taking on downside risk in value-based arrangements.

5. Notable Q&A Insights

• Medicare Advantage (MA) Strategy: Management expressed confidence in the MA market, highlighting a focus on shared risk arrangements while maintaining a cautious stance on full capitation.
• Provider Integration: Early integration of Evolent assets is progressing well, with expectations of improved performance in shared savings.
• Market Dynamics: Discussions highlighted potential consolidation in the healthcare sector, with opportunities for Privia to benefit from the unwinding of traditional health system models.
• Prior Authorization Policies: Management noted that changes in prior authorization policies are unlikely to significantly impact their business, given the nature of their primary care-centric model.

Overall, Privia Health reported a strong start to 2026, with solid financial performance and strategic positioning for future growth, despite some cautious outlooks on shared savings and risk management.